Literature DB >> 26182137

Mixed acinar-endocrine carcinoma of the pancreas treated with S-1.

Yusuke Kanemasa1, Terumi Kamisawa2, Taku Tabata1, Sawako Kuruma1, Susumu Iwasaki1, Kazuro Chiba1, Go Kuwata1, Takashi Fujiwara1, Hideto Egashira1, Koichi Koizumi1, Junko Fujiwara1, Takeo Arakawa1, Kumiko Momma1, Hirofumi Rokutan3, Shinichiro Horiguchi3, Tsunekazu Hishima3.   

Abstract

The case of a 63-year-old male with a large mass in the pancreatic tail and multiple liver metastases, diagnosed as acinar cell carcinoma of the pancreas with a few scattered endocrine cells by liver biopsy is presented. The S-1 chemotherapy was effective, and partial response was obtained with decreased levels of serum CA19.9 and NSE. Ten months after starting chemotherapy, the tumor began to grow accompanied by marked elevation of serum NSE levels (266 ng/ml). The patient died of liver failure due to multiple liver metastasis 18 months after the initiation of the S-1 chemotherapy. Histological findings at autopsy were acinar cell carcinoma with an endocrine component of more than 30 %; the final diagnosis was mixed acinar-endocrine carcinoma of the pancreas. This pathological change and clinical course may imply that S-1 was effective against the acinar component but less effective against the neuroendocrine component caused by tumor differentiation.

Entities:  

Keywords:  Acinar cell carcinoma; Mixed acinar-endocrine carcinoma; Pancreas; S-1

Year:  2013        PMID: 26182137     DOI: 10.1007/s12328-013-0416-8

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  27 in total

1.  Immunohistochemical analysis and clinical course of high-malignant composite endocrine-acinar cell carcinoma: a case report.

Authors:  M Frank; A Bittinger; M Rothmund; R Arnold
Journal:  Pancreas       Date:  1998-08       Impact factor: 3.327

2.  Mixed exocrine-endocrine tumor of the pancreas.

Authors:  Konstantinos D Ballas; Savas F Rafailidis; Charalampos Demertzidis; Michael B Alatsakis; Afroditi Pantzaki; Athanassios K Sakadamis
Journal:  JOP       Date:  2005-09-10

3.  Acinar cell carcinoma of the pancreas: computed tomography features--a study of 15 patients.

Authors:  Siva P Raman; Ralph H Hruban; John L Cameron; Christopher L Wolfgang; Satomi Kawamoto; Elliot K Fishman
Journal:  Abdom Imaging       Date:  2013-02

4.  Four cases of pancreatic acinar cell carcinoma treated with gemcitabine or S-1 as a single agent.

Authors:  Yoshitaka Seki; Takuji Okusaka; Masafumi Ikeda; Chigusa Morizane; Hideki Ueno
Journal:  Jpn J Clin Oncol       Date:  2009-08-08       Impact factor: 3.019

Review 5.  A case of mixed acinar-endocrine carcinoma of the pancreas discovered in an asymptomatic subject.

Authors:  T Ogawa; S Isaji; T Yabana
Journal:  Int J Pancreatol       Date:  2000-06

6.  Acinar cell carcinoma of the pancreas: a possible role of S-1 as chemotherapy for acinar cell carcinoma. A case report.

Authors:  Tameyoshi Yamamoto; Hiroki Ohzato; Mutumi Fukunaga; Hiroshi Imamura; Hiroshi Furukawa
Journal:  JOP       Date:  2012-01-10

7.  CT and MRI features of pure acinar cell carcinoma of the pancreas in adults.

Authors:  Servet Tatli; Koenraad J Mortele; Angela D Levy; Jonathan N Glickman; Pablo R Ros; Peter A Banks; Stuart G Silverman
Journal:  AJR Am J Roentgenol       Date:  2005-02       Impact factor: 3.959

Review 8.  Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.

Authors:  Monique Antoine; Marina Khitrik-Palchuk; Muhammad Wasif Saif
Journal:  JOP       Date:  2007-11-09

9.  Mixed acinar-endocrine carcinomas of the pancreas.

Authors:  D S Klimstra; J Rosai; C S Heffess
Journal:  Am J Surg Pathol       Date:  1994-08       Impact factor: 6.394

10.  Hints to the diagnosis of mixed acinar-endocrine carcinoma on pancreatic fine-needle aspiration: avoiding a potential diagnostic pitfall.

Authors:  Peggy S Sullivan; Jennifer L Clebanoff; Sharon L Hirschowitz
Journal:  Acta Cytol       Date:  2013-04-25       Impact factor: 2.319

View more
  6 in total

1.  Serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death ligand 1 (sPD-L1) in advanced pancreatic cancer.

Authors:  Stephan Kruger; Marie-Louise Legenstein; Verena Rösgen; Michael Haas; Dominik Paul Modest; Christoph Benedikt Westphalen; Steffen Ormanns; Thomas Kirchner; Volker Heinemann; Stefan Holdenrieder; Stefan Boeck
Journal:  Oncoimmunology       Date:  2017-03-31       Impact factor: 8.110

2.  Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature.

Authors:  Jian-Ying Xu; Wen-Long Guan; Shi-Xun Lu; Xiao-Li Wei; Wen-Jie Shi; Chao Ren; Yu-Hong Li; Sheng-Ping Li; Miao-Zhen Qiu; Feng-Hua Wang
Journal:  Clin Med Insights Oncol       Date:  2022-04-30

3.  A case report of mixed acinar-endocrine carcinoma of the pancreas treated with S-1 chemotherapy: Does it work or induce endocrine differentiation?

Authors:  Masataka Yokode; Ryosuke Itai; Yukimasa Yamashita; Yoh Zen
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

4.  Long-Term Efficacy of S-1 Chemotherapy plus Administration of Octreotide for a Patient with Metastatic Neuroendocrine Tumor (Gastrinoma).

Authors:  Sakura Hiraide; Sadahide Ono; Satoshi Kato
Journal:  Case Rep Oncol       Date:  2017-05-08

5.  Metastatic mixed acinar-endocrine carcinoma of the pancreas treated with a multidisciplinary approach: a case report.

Authors:  Takeo Hara; Yoshiyuki Fujiwara; Hidenori Takahashi; Keijiro Sugimura; Jeong-Ho Moon; Takeshi Omori; Norikatsu Miyoshi; Akira Tomokuni; Hirofumi Akita; Shogo Kobayashi; Masayoshi Yasui; Hiroshi Miyata; Masayuki Ohue; Masato Sakon; Yasuhiko Tomita; Masahiko Yano
Journal:  Surg Case Rep       Date:  2017-03-30

6.  Mixed Acinar-Endocrine Carcinoma (MAEC) Arising in Duodenal Pancreatic Heterotopia.

Authors:  Phoenix D Bell; Tom C DeRoche; Aaron R Huber
Journal:  Case Rep Pathol       Date:  2019-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.